Inactive Instrument
Ark Therapeutics Group plc Stock London S.E.
Stocks
GB0034251727
OTC Markets Traded|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 5.29M 7M 6.34M 5.87M 9.98M 660M 10.33M 70.49M 27.95M 353M 26.27M 25.72M 1.12B | P/E 2024 |
1.51x | P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | -9.39M -12.42M -11.26M -10.41M -17.7M -1.17B -18.33M -125M -49.59M -626M -46.61M -45.62M -1.99B | EV / Sales 2024 |
-0.1x | EV / Sales 2025 | -0.56x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 01/07/16 | Premier Veterinary : Appointment of Broker | PU |
| 28/06/16 | Premier Veterinary : Further Major Agreement Signed in the US | PU |
| 21/06/16 | Premier Veterinary : Director's Dealings | PU |
| 21/06/16 | Premier Veterinary : Block Listing Application and Directors' Dealings | PU |
| 14/06/16 | Premier Veterinary : Director's Dealings | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Dominic Tonner
CEO | Chief Executive Officer | 69 | 27/02/2015 |
Andrew Paull
DFI | Director of Finance/CFO | 52 | 30/11/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Graham Dick
CHM | Chairman | 75 | 01/03/2018 |
Dominic Tonner
BRD | Director/Board Member | 69 | 27/02/2015 |
Rajan Uppal
BRD | Director/Board Member | 64 | 27/02/2015 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.53M 21.86M 19.81M 18.32M 31.15M 2.06B 32.25M 220M 87.27M 1.1B 82.03M 80.29M 3.49B | 16.85M 22.28M 20.19M 18.67M 31.75M 2.1B 32.87M 224M 88.95M 1.12B 83.61M 81.84M 3.56B |
| Net income | 3.9M 5.16M 4.68M 4.33M 7.36M 487M 7.62M 51.99M 20.62M 260M 19.38M 18.97M 826M | 3.64M 4.82M 4.37M 4.04M 6.87M 454M 7.11M 48.52M 19.24M 243M 18.08M 17.7M 770M |
| Net Debt | -6.94M -9.18M -8.32M -7.69M -13.08M -865M -13.54M -92.4M -36.64M -462M -34.44M -33.71M -1.47B | -14.69M -19.42M -17.6M -16.28M -27.68M -1.83B -28.66M -196M -77.54M -978M -72.89M -71.34M -3.11B |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
